Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400.
Future Horizons and Growth Strategies in the US Cancer Diagnostics Market 2015 is a newstrategic analysis of the major business opportunities emerging in the cancer diagnostics market during the nextfive years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially
significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Cancer Diagnostic TestsOver 200 current and emerging assays including:
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,
Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,
Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,
Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,
Tissue Polypeptide Antigen, and others.
Market Segmentation Analysis
- Sales and market shares of major suppliers,
by individual cancer diagnostic test.
- Five-year test volume and sales forecasts
for major cancer diagnostic tests by market segment, including:
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers.
- Cancer statistics, etiology and recent developments.
Current and Emerging Products
- Review of over 200 current and emerging cancer diagnostic tests,
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Immunohistochemical Stains, and others.
- Analysis of major immunoassay analyzers used for
cancer diagnostic testing, including their operating characteristics,
features and selling prices.
- Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and other technologies
and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.
- Extensive listings of over 500 companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.
- Strategic assessments ofmajor suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.
Contains 620 pages and 103 tables
SIMILAR MARKET STUDIES
Complete report $1,850. DataPack (test volumes, sales forecasts, supplier shares) $1,200. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and ...
August 2015 | $1200 | View Details >>
?New Frontiers in the German Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape? is Venture Planning Group?s new study of the major business opportunities emerging in the German clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the ...
May 2014 | $3950 | View Details >>
This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Table of Contents Business Environment Market Structure Market Size, Growth, and Major Suppliers' Market SharesList of TablesTest Volume Forecasts by Market Segment Sales Forecasts by ...
July 2016 | $0 | View Details >>
Notes: Sales, means the sales volume of Bleed Valve Revenue, means the sales value of Bleed Valve This report studies sales (consumption) of Bleed Valve in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for ...
February 2017 | $3900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research